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Summary. Aldehyde oxidase (EC 1.2.3.1) is a 
xenobiotic metabolizing enzyme that catalyzes a variety 
of organic aldehydes and N-heterocyclic compounds. 
However, its precise pathophysiological function in 
humans, other than its xenobiotic metabolism, remains 
unknown. In order to gain a better understanding of the 
role of this enzyme, it is important to know its exact 
localization in human tissues. In this study, we  
investigated the distribution of aldehyde oxidase at the 
cellular leve1 in a variety of human tissues by 
immunohistochemistry. The enzyme was found to be 
widespread in respiratory, digestive, urogenital, and 
endocrine tissues, though we also observed a cell- 
specific localization in the various tissues studied. In the 
respiratory system, it was particularly abundant in 
epithelial cells from the trachea and bronchium, as well 
as alveolar cells. In the digestive system, aldehyde 
oxidase was observed in surface epithelia of the small 
and large intestines, in addition to hepatic cells.  
Furthermore, the proximal, distal, and collecting tubules 
of the kidney were immunostained with various 
intensities, while glomerulus tissues were not. In 
epididymus and prostate tissues, staining was observed 
in the ductuli epididymidis and glandular epithelia. 
Moreover, the adrenal gland, cortex, and notably the 
zona reticularis, showed strong immunostaining. This 
prevalent tissue distribution of aldehyde oxidase in 
humans suggests some additional pathophysiological 
functions besides xenobiotic metabolism. Accordingly, 
some possible roles are discussed. 
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lntroduction 
Aldehyde oxidase (EC 1.2.3.1) is a xenobiotic 
metabolizing enzyme that catalyzes a variety of organic 
aldehydes and N-heterocyclic compounds, with a 
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substrate specificity similar to that of xanthine oxidase 
(Beedham, 1985). We have previously described the 
histochemical localization of this enzyme in various rat 
tissues (Moriwaki et al., 1996). However, histochemical 
localization studies of aldehyde oxidase have not been 
performed thus far in human tissues, except for the 
spinal cord by in situ histochemistry (Berger et al., 
1995), as its activity in humans is very low compared to 
rats, thus rendering it difficult to be purified and to raise 
specific antibodies. Although aldehyde oxidase has been 
suggested to be involved in biogenic amine metabolism 
(Beedham et al., 1995), its pathophysiological role in 
humans remains unknown. Recently, the primary amino 
acid sequence of human aldehyde oxidase was 
determined (Wright et al., 1993; Terao et al., 1998). In 
the present study, we developed a specific polyclonal 
antibody against human aldehyde oxidase using a 
synthetic peptide sequence, and then investigated the 
distribution of aldehyde oxidase in various human 
tissues, using immunohistochemical staining procedures, 
to obtain information about its precise localization and 
gain a better understanding of the role of this enzyme in 
various human tissues. 
Materials and methods 
Tissue cytoplasmic protein (human adult normal 
tissue protein) was purchased from BioChain Institute 
Inc. (Hayward, CA, USA). Paraffin-embedded normal 
human tissue samples were obtained from Novagen Inc. 
(Madison, WI, USA) and then subjected to 
immunohistochemical staining. Some of the tissue 
samples were obtained from corpses as soon as possible 
after death, and then fixed in 4% paraformaldehyde-PBS 
(0.01M phosphate-buffered saline, pH 7.4), embedded in 
paraffin at 60 O C ,  and subjected to immunohistochemical 
staining. 
Preparation of polyclonal antibody against human 
aldehyde oxidase 
KLH-peptide conjugate was employed as an antigen 
lmmunohistochemistry of human aldehyde oxidase 
to construct a human aldehyde oxidase antibody. The 
peptide sequence, Cys-Ser-Thr-Leu-Lys-Try-Gln-Asn- 
Ile-Gly-Pro-Lys-Gln-His-Pro-Glu-Asp-Pro-, located 
at amino acid position 562 to 580 of the human aldehyde 
oxidase, was synthesized by a peptide sequencer and 
purified using an HPLC. The synthetic polypeptide was 
conjugated with a carrier protein by means of the KLH 
by MBS (m-Maleimidobenzoyl-N-hydroxysuccinimide 
ester) method. Two hundred micrograms of KLH- 
peptide conjugate with Freund's complete adjuvant was 
subcutaneously injected into a male white rabbit. 
Thereafter, immunizations with 100 p g  of KLH-peptide 
conjugate with Freund's incomplete adjuvant were 
repeated five times within a two-week period. Seven 
days after the final immunization, blood was withdrawn, 
separated by centrifugation at x1700g for 10 min, and 
warmed to 56 "C for 30 min. Solid (NH4)2S04 was then 
slowly added with gentle stirring to the resultant serum 
to obtain a final concentration of 30%. The suspension 
was allowed to stand for 30 min, and then fractionated 
by centrifugation at x5000g for 30 min. The pellet was 
discarded and additional (NH4)+04 was added to the 
supernatant to obtain a 50% saturation. After a second 
centrifugation at x5000g for 30 min, the supernatant was 
discarded and the pellet was resuspended and dialyzed 
against PBS, affinity purified with a Tresyl column 
(TOSOH, Tokyo, Japan) and then used as a polyclonal 
antibody against human aldehyde oxidase. 
Specificity testing of the antibody against human 
aldehyde oxidase 
The specificity of the polyclonal antibody for human 
aldehyde oxidase was fully confirmed by immunoblot 
analysis. After electrophoresis, cytoplasrnic protein 
samples from the respective tissues were transferred 
electrophoretically from a polyacrylamide gel to a PVDF 
membrane. The PVDF membrane was blocked overnight 
at 4 "C in Block Ace (Dainippon Pharmaceutical Co. 
Ltd, Tokyo, Japan). After being rinsed with TBS (0.05M 
Tris-buffered saline, pH 7.4) containing 0.05% Tween 20 
(TBST), the PVDF membrane was incubated for 1 hour 
at room temperature with 4 pglmL of Tresyl column 
affinity purified polyclonal antibody against human 
aldehyde oxidase in 25% Block Ace. The  PVDF 
membrane was washed three times with TBST, 10 min 
each time, and then incubated at room temperature for 
30 min with a labeled polymer (ENVISION t, Dako 
Corporation, Carpinteria, CA, USA). The membrane was 
washed again three times with rinse buffer, for 10 min 
each time. Aldehyde oxidase protein was then visualized 
by use of a Liquid DAB substrate-chromogen system 
(Dako Corporation). 
lmmunohistochemical procedures 
Immunolocalization of aldehyde oxidase in the 
tissue sections was performed according to labeled 
polymer techniques. The  tissue sections were 
deparaffinized, hydrated, and treated with proteinase K 
(Dako Corporation) for 6 min. Endogenous peroxidase 
activity in the tissues was eliminated by preincubation 
with 3% H202  in methanol for 10 min. After three 
washes with PBS for 5 min, the tissue sections were 
placed in a blocking reagent (Protein Block Serum-Free, 
Dako Corporation) for 10 min to reduce nonspecific 
staining of the bridging antibody, and then incubated 
overnight with the Tresyl column affinity purified 
polyclonal antibody against human aldehyde oxidase (4 
pg/mL) in 25% Block Ace in PBS at 4 "C. After being 
washed 3 times for 5 min in PBS, the sections were 
incubated at room temperature for 3 0  min with 
ENVISION +. Following washing with PBS 3 times for 
5 min, the sections were placed in a Liquid DAB 
substrate-chromogen system for 5 to 10  min. The 
intensity of the staining was controlled while viewing 
through a microscope. Counterstaining was performed 
with Mayer hemalum solution (Diagnostica Merck, 
Darmstadt, Germany). Finally, after a wash in PBS, the 
sections were dehydrated in a graded ethanol series and 
mounted in resin-based permanent mounting medium 
(ShandonILipshaw Co., Pittsburgh, PA, USA). As 
control immunostainings, sections were incubated in the 
same manner, except that the prirnary antibody was 
replaced by normal rabbit IgG (Rabbit immunoglobulin 
fraction, negative control, Dako Corporation). 
Results 
Specificity of anti-aldehyde oxidase polyclonal antibody 
and expression of aldehyde oxidase protein in human 
tissues by immunoblot analysis 
The specificity of the polyclonal antibody against 
human aldehyde oxidase was checked by immunoblot 
analysis using normal human liver cytoplasmic extract. 
As illustrated in Fig. 1, lane 1, a single major band of 
MW at approximately 150kd was detected in the liver 
cytoplasmic extract. In addition, the liver tissues showed 
a significant proportion of an aldehyde oxidase fragment 
of proteolytic origin, which was probably due to the high 
concentration of protease normally present in this organ. 
The amount of aldehyde oxidase protein in various 
human tissues was also determined by immunoblot 
analysis.  A faint to moderate single band at the 
molecular weight of 150 kd corresponding to aldehyde 
oxidase protein was observed in specimens from the 
prostate (Fig. 1, lane 9), adrenal gland (Fig. 1, lane l l ) ,  
and testis tissues (Fig. 1, lane 12). In contrast, no protein 
band corresponding to aldehyde oxidase was detectable 
in the lung, kidney, large intestine, small intestine, 
cerebrum, heart, pancreas, or stomach tissues (Fig. 1, 
lane 2- 8, 10). 
Expression of aldehyde oxidase protein in human tissues 
by immunohistochemistry 
The tissue distribution of human and rat aldehyde 
lmmunohistochemistry of human aldehyde oxidase 
oxidase protein i s  summarized in Table 1.  The 
distribution of reactivity obsemed in various tissues was 
as follows. 
Digestive tissue 
Hepatocytes and sinusoidal lining cells displayed 
diffuse staining for aldehyde oxidase. However, the 
reactivity for aldehyde oxidase was unevenly distributed, 
as it was more intense in the pericentral hepatocytes 
around the central vein than in the periportal hepatocytes 
around the portal triad, which was similar to the results 
found for the rat liver (Fig. 2a). In addition, the bile duct 
showed a moderate immunostaining (Fig. 2a, arrow). In 
the esophagus, faint immunostaining was obsemed at the 
basa1 layer of the surface epithelia (data not shown), 
while stomach specimens were not immunostained (Fig. 
2c). In the small and large intestines, a faint reaction was 
recognized on the surface epithelia. However, no 
reaction was obsemed in the respective glandular cells 
(Fig. 2e,g). The lamina propria in the small intestine was 
also immunostained (Fig. 2e). In contrast, control 
sections treated with normal rabbit IgG did not show 
staining (Fig. 2b,d,f,h). 
Cardiovascular tissue 
Cardiac and skeletal muscle cells, as well as those 
from the aorta, were not immunostained for aldehyde 
oxidase (data not shown). 
Respiratory tissue 
Surface epithelia of the bronchium were moderately 
stained for aldehyde oxidase, while alveolar cells were 
strongly immunostained (Fig. 3a,c). Cartilage cells were 
also stained, but those of the bronchial glands were not 
(Fig. 3a, arrow). Control sections treated with normal 
rabbit IgG did not show staining (Fig. 3b,d). 
Urinary system tissue 
In the kidney, the proximal, distal, and collecting 
tubules were immunostained for akiehyde oxidase with 
Fig. l. lmmunoblot analysis of aldehyde oxidase from various human tissues. Cytoplasmic proteins (25 pg per lane) were loaded onto a 7.5% SDS- 
polyacrylamide gel and subjected to immunoblot analysis. After transfer, the PVDF membranes were hybridized with the anti-human aldehyde oxidase 
polyclonal antibody. lmmunoreactive bands were visualized with the use of DAB, after incubation with a second antibody linked to horseradish 
peroxidase. Molecular markers are indicated in the left column (200 kd. myosin H-chain; 97 kd, phosphorylase b; 68 kd, ovalbumin; 29 kd, carbonic 
anhydrase). Lane 1, liver; lane 2, lung; lane 3, kidney; lane 4, large intestine; lane 5, small intestine; lane 6. cerebrum; lane 7, heart; lane 8, pancreas; 
lane 9, prostate; lane 10, stomach; lane 11, adrenal gland; and lane 12, testis. A single band at the molecular weight of 150 kd corresponding to 
aldehyde oxidase protein is obse~ed in specimens from the adrenal gland (moderate), testis (moderate), and prostate (weak), while the liver (strong) 
shows a significant proportion of an aldehyde oxidase fragment of proteolytic origin, probably due to the high concentration of protease present in this 
organ, in addition to a single band at the molecular weight of 150 kd. 
Table 1. Summary of aldehyde oxidase distribution in human and rat 
tissues. various intensities, while glomerulus specimens were not (Fig. 4a). These staining patterns were very similar to 
those of rat kidney. Control sections treated with normal 
rabbit IgG did not show staining (Fig. 4b). Human Rat 
Resplratofy tlssues 
Throat 
Lung 
Trachea 
Bronchium 
Alveolus 
Urlnary tlssues 
Kidney 
Glomerulus 
Proximal tubule 
Distal tubule 
Collecting tubule 
Bladder 
Transitional cells 
Prostate 
Glands 
Dlgestlve tlssues 
tiver 
Pericentral hepatocyte 
Periportal hepatocyte 
Bile dcut 
Pancreas 
Acinus 
Duct 
lslet of Langerhans 
Parotid gland 
Esophagus 
Epithelium, basal layer 
Epithelium, intermediate layer 
Epithelium, superficial layer 
Glands 
Muscle 
Stomach 
Surface mucous cell 
Gastric glands 
Small intestine 
Columnar epithelium 
Goblet cells 
Intestinal glands 
Lamina propria 
Endocrlne tlssues 
Adrenal 
Zona glomerulosa 
Zona fasciculata 
Zona reticularis 
Testis 
Spermatogonium 
Spermatozoa 
Ovary 
Thyroid 
Neunil tlssues 
Brain 
Spinal cord 
CardIovascular tlssues 
Heart 
Aorta 
Reproductlve tlssues 
Epídidymus 
Endocrine tissue 
Strong immunostaining was observed in the adrenal 
gland samples. There was a staining gradient observed 
across the specimens, with the zona reticularis having 
the highest leve1 (Fig. 4c). These staining patterns were 
strikingly different from those of the rat adrenal gland, 
which showed no staining, though they resembled rat 
xanthine oxidase. In contrast, neither the thyroid nor 
pancreas specimens had any staining for aldehyde 
oxidase (data not shown). Corítrol sections treated with 
normal rabbit IgG did not show staining (Fig. 4d). 
Reproductive tissue 
In the prostate and epididymus, strong 
immunostaining was observed in the tubulo-alveolar 
prostatic gland epithelia (Fig. 5a) and ductuli  
epididymidis (Fig. 5c), while seminal vesicles were 
intensely immunostained for aldehyde oxidase (data not 
shown). Furthermore, the longitudinal folds of the 
fallopian tube mucosa showed staining, though the ovary 
specimens did not (data not shown). Control sections 
treated with normal rabbit IgG did not show staining 
(Fig. Sb,d). 
Lymphoid tissues 
Lymphoid tissues from the thymus, lymph node, 
tonsil, and spleen were not labeled for aldehyde oxidase 
(data not shown). 
Neural tissues 
Neural tissues from the medulla oblongata, Corpus 
callosum, spinal cord, peripheral nerve, cerebral cortex, 
mesencepharon, cerebellum, pons, and hippocampus 
were not stained for aldehyde oxidase (data not shown). 
Other tissues 
Salivary gland, skin, and uterus specimens were not 
immunostained for aldehyde oxidase (data not shown). 
Discusslon 
Purification of aldehyde oxidase has been performed 
using liver specimens from rabbits (Stell et al., 1989), 
guinea pigs (Yoshihara and Tatsumi, 1985), mice 
(Yoshihara and Tatsumi, 1997a,b), hogs (Li Calzi et al., 
1995), and hurnans (Johns, 1967). However, aldehyde 
oxidase activity in the human liver is much lower when 
compared to that in rat, rabbit, or guinea pig livers. As a 
result, it is difficult to purify human aldehyde oxidase to 
-: no staining; I: equivoca1 staining; +: low staining; ++: moderate 
staining; +++: high staining; ND: not described. Results of tissue 
distribution of rat aldehyde oxidase are cited from Histochem. Cell Biol. 
1996; 105: 71-79 (Moriwaki et al.). 
Immunohistochemistty of human aldehyde oxidase 
the point of homogeneity and to raise an antibody using provided an important tool for the detection of aldehyde 
the purified enzyme. Recently, the primary amino acid oxidase in human tissues at the protein leve1 as well as at 
sequence of human aldehyde oxidase was determined the mRNA level. 
(Wright et al., 1993; Terao et al., 1998), which has The present study was undertaken to: 1) determine 
lmmunohistochemistry of human aldehyde oxidase 
the distribution of human aldehyde oxidase protein in 
various tissues; 2) compare the leve1 of aldehyde oxidase 
protein in the liver with that of other tissues; and 3) 
compare the distribution of aldehyde oxidase protein in 
various human tissues with that of rat tissues. 
The present method of immunohistochemistry, using 
a sensitive and specific polyclonal antibody, enabled us 
to map the cellular distribution of aldehyde oxidase 
protein in a variety of human tissues. Our results were 
similar to those of Moriwaki et al. (1996) and Kurosaki 
et al. (1999), who studied aldehyde oxidase protein and 
mRNA levels, respectively, in rats and mice. 
Aldehyde oxidase activity has been exclusively 
observed in hepatic tissues and, s ince i ts  initial 
discovery, the enzyme has been considered to be  
xenobiotic. However, the importante of its widespread 
tissue distribution other than hepatic tissue remains 
unclear, though severa1 pathophysiological functions of 
this protein, other than xenobiotic metabolism, have 
been suggested (Moriwaki et al., 1997). The significance 
of aldehyde oxidase has been implicated in microbicidal 
activity (Badwey et al., 1981), and its localization in 
epithelium may suggest a role in the defense mechanism. 
Furthermore, it has been proposed that aldehyde oxidase 
is also involved in the metabolism of biogenic amine 
(Beedham et al., 1995), alcohol toxicity (Mira et al., 
1995), pheromone degradation (Rybczynski et al., 1989, 
1990), and re-expansion pulmonary edema (Jackson et 
al., 1988). Moreover, the discovery of this enzyme in the 
intestines suggests that it may be involved in protection 
against toxic plants,  as  suggested previously for 
terrestrial gastropods (Large and Connock, 1993). 
Flg. 3. lmrnunohistochemical staining of aidehyde oxidase protein in human respiratory system tissues with the aidehyde oxidase polyclonal antibody. 
In the trachea and brondiium, strong immunostaining is observad in the epithelial cells (EPT) (a). In addition, cartilageous calls are also rnoderately 
immunostained (a, amw). Strong immunostaining is recognized in the alveoli (ALV) (c). Control sections treated with normal rabbit IgG do not show 
staining (b, d). 5-pm parafñn sedons. 
lmmunohistochemistry of human aldehyde oxidase 
The most intriguing finding in the present study was 
the localization of aldehyde oxidase in adrenal gland, 
epididymus, prostate, and testis specirnens, as shown by 
immunoblot analysis and immunohistochemistry results. 
A strong staining intensity gradient was detected across 
the adrenal gland specimens, with the zona reticularis 
having the highest leve1 of staining. This strong staining 
of aldehyde oxidase in the zona reticularis of the adrenal 
gland, as well as in the renal tubules, may suggest a 
possible role in electrolyte and organic ion transport. It 
has previously been demonstrated that aldehyde oxidase 
activity is regulated by testosterone (Kurosaki et al., 
1999) and growth hormone (Yoshihara and Tatsumi, 
1997a,b). Thus, in the present study it is noteworthy that 
aldehyde oxidase was observed in samples from the 
testis, epididymus, and prostate, which are the target 
organs of testosterone. 
Recent studies have demonstrated that aldehyde 
oxidase is  involved in familia1 recessive type of 
amyotrophic lateral sclerosis (Berger et al., 1995; 
Bendotti e t  al., 1997; Wright and Repine, 1997). 
Furthermore, aldehyde oxidase mRNA has been 
observed in mouse and human spinal cords (Berger et 
al., 1995; Bendotti et al., 1997), though its subcellular 
localization was different, in that it was observed in 
large motor neurons in the mouse spinal cord as in the 
glial, but not in the motor neurons in the anterior hom 
neuron of the human spinal cord. In the present study, 
aldehyde oxidase protein was not observed in the spinal 
cord. 
Fig. A lrnrnunohistochmicai staining of abhyide oxkbm protein in human urlnary and endocrlne aygtem thws WH-I iM akbhyda araid#e polyrdonril 
antibody. In Uis kidney, strong bu1 uneven lrnmunostalning is in the proximal (PT), dkhi (DT), mi cdleuthg Ri$wkr (CT), vhwm ths 
glomerull (Gl) oniy has background levels oi immunostainlng (a). A strang Wnlng intenslty 1s demonsoeted in tha admd @md (e). There is an 
aklehyde oxidase staining gradlent a m  the adrenal g l d  sr%s¡rnen, wlth the zona &uWs 0 hrwing the MgM M. c0na.d smctlwrs beéited 
wnti nomei mM¡t lgG do not show stalning @, d). S y m  paraffin 
lmmunohistochemistry of human aldehyde oxidase 
A deficiency of aldehyde oxidase has not yet been 
recognized clinically, though a combined deficiency of 
xanthine oxidase and aldehyde oxidase was suggested in 
an in vivo study using N-methylnicotinamide (Reiter et 
al., 1990). Additionally, previous studies have suggested 
that aldehyde oxidase is  identical to retinal oxidase 
(Tomita et al., 1993; Huang and Ichikawa, 1994). Since 
retinal oxidase plays an important role in the synthesis of 
retinoic acid, which is essential for reproduction, normal 
embryogenesis, morphogenesis, neural development, 
and cellular differentiation (Thaller and Eichele, 1987; 
Levine and Hoey, 1988), it may be speculated that a 
deficiency of aldehyde oxidase is likely to affect these 
crucial processes. Studies  on  aldehyde oxidase 
deficiency using knock-out mice will be required to 
elucidate the role of aldehyde oxidase in these processes. 
In conclusion, the widespread tissue distribution of 
aldehyde oxidase in humans does not provide an 
immediate clue to its biological functions. However, its 
expression in these selective sites may be of significance 
and could provide evidence regarding its action. 
Therefore, the present study may serve to improve the 
understanding of the pathophysiological role of aldehyde 
oxidase in humans, though the significance of its 
prevalent distribution, other than the liver, seems to be a 
matter for future research. 
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